Valuation Virbac

Stocks

Real-time Euronext Paris 07:19:34 28/10/2026 pm IST			5-day change	1st Jan Change
349.00 ^EUR	+0.14%		+0.72%	-2.66%

20/10	Virbac: A well-done Q3 validates underlying quality
20/10	Virbac stock little changed despite strong update and targets now expected at the top end of the range

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	3,584	1,927	3,035	2,651	2,995	2,921	-	-
Change	-	-46.24%	57.52%	-12.67%	13%	-2.47%	-	-
Enterprise Value (EV) ¹	3,510	1,848	2,983	2,819	3,168	3,029	2,961	2,868
Change	-	-47.37%	61.45%	-5.49%	12.37%	-4.38%	-2.26%	-3.14%
P/E	31.7x	15.8x	25x	18.3x	19.9x	16.9x	15.2x	13.9x
PBR	4.95x	2.29x	3.34x	2.54x	2.66x	2.27x	2x	1.75x
PEG	-	2.06x	-72.15x	0.9x	5.23x	1.1x	1.4x	1.49x
Capitalization / Revenue	3.37x	1.58x	2.43x	1.9x	2.04x	1.88x	1.77x	1.68x
EV / Revenue	3.3x	1.52x	2.39x	2.02x	2.16x	1.95x	1.79x	1.65x
EV / EBITDA	16.3x	8.27x	12.8x	9.96x	10.9x	9.5x	8.4x	7.48x
EV / EBIT	20.8x	10.1x	16.1x	12.4x	13.8x	11.7x	10.3x	9.19x
EV / FCF	36.5x	40.7x	50.8x	22.8x	29.7x	34.3x	24.3x	19.2x
FCF Yield	2.74%	2.46%	1.97%	4.39%	3.37%	2.91%	4.11%	5.2%
Dividend per Share ²	1.25	1.32	1.32	1.45	1.45	1.724	2.041	2.382
Rate of return	0.29%	0.58%	0.37%	0.46%	0.41%	0.49%	0.59%	0.68%
EPS ²	13.4	14.43	14.38	17.34	18	20.67	22.88	25.01
Distribution rate	9.33%	9.15%	9.18%	8.36%	8.06%	8.34%	8.92%	9.52%
Net sales ¹	1,064	1,216	1,247	1,397	1,465	1,556	1,650	1,737
EBITDA ¹	215.1	223.4	232.8	283	289.5	319	352.4	383.3
EBIT ¹	168.9	182.8	184.9	227.5	229.7	259	286.1	311.9
Net income ¹	113.2	122	121.3	145.3	150.9	173.2	192.9	211.5
Net Debt ¹	-73.83	-79.36	-52.36	168.5	172.8	108.2	39.59	-53.28
Reference price ²	424.50	228.00	359.50	316.50	357.50	348.50	348.50	348.50
Nbr of stocks (in thousands)	8,443	8,451	8,443	8,375	8,378	8,382	-	-
Announcement Date	22/03/22	23/03/23	19/03/24	13/03/25	17/03/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
VIRBAC	16.86x	1.95x	9.5x	0.49%	325.46Cr
ELI LILLY AND COMPANY	37.66x	13.18x	27.98x	0.53%	1,14300Cr
JOHNSON & JOHNSON	39.33x	6.61x	18.6x	1.99%	65TCr
ABBVIE INC.	37.45x	8.4x	17.37x	2.4%	51TCr
ROCHE HOLDING AG	21.46x	5.22x	12.98x	2.51%	38TCr
MERCK & CO., INC.	103.38x	5.8x	24.86x	2.4%	35TCr
NOVARTIS AG	21.99x	5.69x	13.69x	2.94%	29TCr
ASTRAZENECA PLC	22.31x	4.51x	12.87x	1.96%	26TCr
AMGEN INC.	28.42x	7.28x	13.03x	2.25%	24TCr
GILEAD SCIENCES, INC.	-45.78x	7.1x	27.53x	2.07%	20TCr
Average	28.31x	6.57x	17.84x	1.96%	40.31TCr
Weighted average by Cap.	35.26x	8.35x	20.47x	1.8%